Personalized Pathways: Redefining Frontline Hodgkin Lymphoma Treatment Strategies

In this episode, Jonathan W. Friedberg, MD; Alex F. Herrera, MD; and Kara Kelly, MD, discuss the latest frontline treatment options for advanced Hodgkin lymphoma (HL) and approaches to personalizing treatment for the general patient population, older patients, and pediatric patients. This podcast was adapted from a live presentation held in May 2025.The Landscape of Frontline Options in HLSpecial Considerations for Older PatientsSpecial Considerations for Pediatric PatientsFuture Directions in HLPresenters:Jonathan W. Friedberg, MDDirector, Wilmot Cancer InstituteSamuel Durand Professor of Medicine and OncologyUniversity of RochesterRochester, New YorkAlex F. Herrera, MDChief, Division of LymphomaProfessor, Department of Hematology and Hematopoietic Cell TransplantationMedical Director of the City of Hope Clinical Trials OfficeAssociate Medical Director of the Briskin Center for Clinical ResearchCity of Hope Medical CenterDuarte, CaliforniaKara M. Kelly, MDWaldemar J. Kaminski Endowed Chair of PediatricsRoswell Park Comprehensive Cancer CenterDivision Chief and Professor of PediatricsUniversity at Buffalo Jacobs School of Medicine and Biomedical SciencesBuffalo, New YorkContent based on an online CME program supported by an independent educational grant from Bristol Myers Squibb.Link to CME: Claim Credithttps://bit.ly/3TQ0M45Link to full program: https://bit.ly/4eV8AuW

There are no comments yet.

Please log in to write the first comment.